USPTO 2015–2025 USPTO PatentsView US Corporation

Medivest, LLC

USPTO PatentsView assignee record - 7 granted patents across 2 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Medivest ranks #36,438 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 2 technology areas.

#36,438
of 49,997 US assignees by volume
27th percentile
by Innovation Score (28.4/100)
21.4
avg claims per patent
-60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36438 · US Corporation #36,438 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 7 grants
  • MID-PACK #36,438/49,997
  • PHOTO-FINISH Medicom Innovation…
  • CPC-NARROW A61F · 2 areas
  • INNOV-THIN 28.4/100
  • CLAIMS-DENSE 21.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -60% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Medicom Innovation Partner A/S (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Medivest

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Medivest's Innovation Score is 28.4/100 (27th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Medivest's grants concentrate

Medivest, LLC is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). By volume, Medivest sits between Medicom Innovation Partner A/S and Meilleur Co., Ltd.

Medivest's three-year grant acceleration

Medivest, LLC shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Medivest's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medivest holds 7 patents at rank #36,369, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medivest

By rank, the assignees closest to #36,369 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Medivest's primary technology class.

Medivest's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 27th percentile higher than 27% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1 2015201620172018201920202023 1
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Medivest, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 14.3%
2016 1 14.3%
2017 1 14.3%
2018 1 14.3%
2019 1 14.3%
2020 1 14.3%
2023 1 14.3%

Where it ranks

Overall rank by patents

#36,438

of 49,997 tracked assignees

Innovation Score

28.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Medivest, LLC's patent record in context - here's where to go next.

  • Medivest, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #36,438 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Medivest, LLC against Medicom Innovation Partner A/S, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 28.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.